Related Directory Categories
Sources
Help build the largest human-edited directory on the web.
Submit a site - Become an editor
Wikipedia. Licensed under the GNU Free Documentation License.
Are you an expert in this subject? Join the discussion and share your knowledge at Wikipedia.org.
Maple syrup urine disease
From Wikipedia, the free encyclopedia
| This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (November 2007) |
 |
|
|---|---|
| Leucine (pictured above), isoleucine, and valine are the branched-chain amino acids which build up in MSUD. | |
| ICD-10 | E71.0 |
| ICD-9 | 270.3 |
| OMIM | 248600 |
| DiseasesDB | 7820 |
| MedlinePlus | 000373 |
| eMedicine | ped/1368 |
| MeSH | D008375 |
Maple syrup urine disease (MSUD), also called branched-chain ketoaciduria, is an autosomal recessive metabolic disorder affecting branched-chain amino acids. It is one type of organic acidemia.[1]
Contents |
MSUD is caused by a deficiency of the metabolic enzyme branched-chain α-keto acid dehydrogenase (BCKDH), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products in the blood and urine.
Characterized in an infant by the presence of sweet-smelling urine, with an odor similar to that of maple syrup, infants with this disease seem healthy at birth but if left untreated suffer severe neurological damage, and eventually die.
From early infancy, symptoms of the condition include poor feeding, vomiting, dehydration, lethargy, hypotonia, seizures, ketoacidosis, and neurological decline.
Maple syrup urine disease can be classified by its pattern of signs and symptoms, or by its genetic cause. The most common and severe form of the disease is the classic type, which appears soon after birth. Variant forms of the disorder may appear later in infancy or childhood and are typically less severe, but still involve mental and physical problems if left untreated.
There are several variations of the disease:
- Classic Severe MSUD
- Intermediate MSUD
- Intermittent MSUD
- Thiamine-responsive MSUD
- E3-Deficient MSUD with Lactic Acidosis
Keeping MSUD under control requires careful monitoring of blood chemistry and involves both a special diet and frequent testing.
A diet with minimal levels of the amino acids leucine, isoleucine, and valine must be maintained in order to prevent neurological damage. As these three amino acids are required for proper metabolic function in all people, specialized protein preparations containing substitutes and adjusted levels of the amino acids have been synthesized and tested, allowing MSUD patients to meet normal nutritional requirements without causing harm.[2]
Usually, patients are also monitored by a dietician. Their diet must be adhered to strictly and permanently. However, with proper management those afflicted are able to live healthy, normal lives and not suffer the severe neurological damage associated with the disease process.
Maple syrup urine disease affects approximately 1 out of 180,000 infants.[3] Due in part to the founder effect,[4] however, MSUD has a much higher prevalence in children of Amish and Mennonite descent.[5][3]
Mutations in the following genes cause maple syrup urine disease:
- BCKDHA (Online 'Mendelian Inheritance in Man' (OMIM) 608348)
- BCKDHB (Online 'Mendelian Inheritance in Man' (OMIM) 248611)
- DBT (Online 'Mendelian Inheritance in Man' (OMIM) 248610)
- DLD (Online 'Mendelian Inheritance in Man' (OMIM) 238331)
These four genes produce proteins that work together as the branched-chain alpha-keto acid dehydrogenase complex. The complex is essential for breaking down the amino acids leucine, isoleucine, and valine, which are present in many kinds of food (particularly protein-rich foods such as milk, meat, and eggs). Mutations in any of these genes reduce or eliminate the function of the enzyme complex, preventing the normal breakdown of leucine, isoleucine, and valine. As a result, these amino acids and their by-products build up in the body. Because high levels of these substances are toxic to the brain and other organs, this accumulation leads to the serious medical problems associated with maple syrup urine disease.
- ^ Ogier de Baulny H, Saudubray JM (2002). "Branched-chain organic acidurias". Semin Neonatol. 7 (1): 65-74. PMID 12069539.
- ^ Hallam P, Lilburn M, Lee PJ (2005). "A new protein substitute for adolescents and adults with maple syrup urine disease (MSUD)". J. Inherit. Metab. Dis. 28 (5): 665-672. doi:10.1007/s10545-005-0061-6. PMID 16151896.
- ^ a b http://rarediseases.about.com/od/rarediseases1/a/062004.htm
About.com: Rare diseases - June 2004. Maple syrup urine disease by Mary Kugler, R.N.
Article describes MSUD prevalence among Amish and Mennonite children. - ^ Jaworski MA, Severini A, Mansour G, Konrad HM, Slater J, Henning K, Schlaut J, Yoon JW, Pak CY, Maclaren N, et al (1989). "Genetic conditions among Canadian Mennonites: evidence for a founder effect among the old country (Chortitza) Mennonites". Clin Invest Med 12 (2): 127-141. PMID 2706837.
- ^ Puffenberger EG (2003). "Genetic heritage of Old Order Mennonites in southeastern Pennsylvania". Am J Med Genet C Semin Med Genet. 121 (1): 18-31. PMID 12888983.
- Overview of condition at NLM Genetics Home Reference
- 1483407370 at GPnotebook
- msud at NIH/UW GeneTests
- Maple Syrup Urine Disease (Overview on NLM)
- MSUD Family Support Group|[1]